View in EDS HTML Full Text PDF Full Text

282 | DURABLE EFFICACY WITH FIXED‐DURATION EPCORITAMAB + POLATUZUMAB, VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA‐R‐CHP) FOR 1L DLBCL (EPCORE NHL‐5).

Saved in:
Bibliographic Details
Title: 282 | DURABLE EFFICACY WITH FIXED‐DURATION EPCORITAMAB + POLATUZUMAB, VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA‐R‐CHP) FOR 1L DLBCL (EPCORE NHL‐5).
Authors: Lavie, D., Kerr, D. A., Avigdor, A., Avivi, I., Belada, D., Abrisqueta, P., Izutsu, K., Grande‐Garcia, C., Yeh, S., Goto, H., Seliem, M., Siddani, S. R., Joshi, N., Noorani, B., Dixit, N., Diness Vindelov, S., Jafarinasabian, P., Thieblemont, C.
Source: Hematological oncology 2025 Supplement; Vol. 43.
Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: EPTOC187726235
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 282 | DURABLE EFFICACY WITH FIXED‐DURATION EPCORITAMAB + POLATUZUMAB, VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA‐R‐CHP) FOR 1L DLBCL (EPCORE NHL‐5).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lavie%2C+D%2E%22">Lavie, D.</searchLink><br /><searchLink fieldCode="AU" term="%22Kerr%2C+D%2E+A%2E%22">Kerr, D. A.</searchLink><br /><searchLink fieldCode="AU" term="%22Avigdor%2C+A%2E%22">Avigdor, A.</searchLink><br /><searchLink fieldCode="AU" term="%22Avivi%2C+I%2E%22">Avivi, I.</searchLink><br /><searchLink fieldCode="AU" term="%22Belada%2C+D%2E%22">Belada, D.</searchLink><br /><searchLink fieldCode="AU" term="%22Abrisqueta%2C+P%2E%22">Abrisqueta, P.</searchLink><br /><searchLink fieldCode="AU" term="%22Izutsu%2C+K%2E%22">Izutsu, K.</searchLink><br /><searchLink fieldCode="AU" term="%22Grande‐Garcia%2C+C%2E%22">Grande‐Garcia, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Yeh%2C+S%2E%22">Yeh, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Goto%2C+H%2E%22">Goto, H.</searchLink><br /><searchLink fieldCode="AU" term="%22Seliem%2C+M%2E%22">Seliem, M.</searchLink><br /><searchLink fieldCode="AU" term="%22Siddani%2C+S%2E+R%2E%22">Siddani, S. R.</searchLink><br /><searchLink fieldCode="AU" term="%22Joshi%2C+N%2E%22">Joshi, N.</searchLink><br /><searchLink fieldCode="AU" term="%22Noorani%2C+B%2E%22">Noorani, B.</searchLink><br /><searchLink fieldCode="AU" term="%22Dixit%2C+N%2E%22">Dixit, N.</searchLink><br /><searchLink fieldCode="AU" term="%22Diness+Vindelov%2C+S%2E%22">Diness Vindelov, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Jafarinasabian%2C+P%2E%22">Jafarinasabian, P.</searchLink><br /><searchLink fieldCode="AU" term="%22Thieblemont%2C+C%2E%22">Thieblemont, C.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> 2025 Supplement; Vol. 43.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>ISSN: </i>0278-0232
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC187726235
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hon.70094_282
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: 282 | DURABLE EFFICACY WITH FIXED‐DURATION EPCORITAMAB + POLATUZUMAB, VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA‐R‐CHP) FOR 1L DLBCL (EPCORE NHL‐5).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lavie, D.
      – PersonEntity:
          Name:
            NameFull: Kerr, D. A.
      – PersonEntity:
          Name:
            NameFull: Avigdor, A.
      – PersonEntity:
          Name:
            NameFull: Avivi, I.
      – PersonEntity:
          Name:
            NameFull: Belada, D.
      – PersonEntity:
          Name:
            NameFull: Abrisqueta, P.
      – PersonEntity:
          Name:
            NameFull: Izutsu, K.
      – PersonEntity:
          Name:
            NameFull: Grande‐Garcia, C.
      – PersonEntity:
          Name:
            NameFull: Yeh, S.
      – PersonEntity:
          Name:
            NameFull: Goto, H.
      – PersonEntity:
          Name:
            NameFull: Seliem, M.
      – PersonEntity:
          Name:
            NameFull: Siddani, S. R.
      – PersonEntity:
          Name:
            NameFull: Joshi, N.
      – PersonEntity:
          Name:
            NameFull: Noorani, B.
      – PersonEntity:
          Name:
            NameFull: Dixit, N.
      – PersonEntity:
          Name:
            NameFull: Diness Vindelov, S.
      – PersonEntity:
          Name:
            NameFull: Jafarinasabian, P.
      – PersonEntity:
          Name:
            NameFull: Thieblemont, C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2025 Supplement
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1099-1069
          Numbering:
            – Type: volume
              Value: 43
          Titles:
            – TitleFull: Hematological oncology
              Type: main
ResultId 1